Cardinal Health, US14149Y1082

Cardinal Health stock heads into the open after a 1.9% decline

Published on 09/18/2026 at 06:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 17, 2026, Cardinal Health stock slipped 1.9 percent to around USD 228 on the NYSE, underperforming the broader US market. The shares remained in the upper half of their 52-week range, with investors looking ahead to upcoming dividend timing and sector news.

Fotorealistisches Pharma-Distributionslager mit Gabelstapler und Mitarbeitern in Dublin Ohio
Cardinal Health Inc. betreibt ein modernes Pharma-Distributionslager in Dublin, Ohio – ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health stock closed at about USD 228 on the New York Stock Exchange on September 17, 2026, down roughly 1.9 percent from the prior session in a modest pullback from recent highs per NYSE data.

September 17, 2026 in numbers

Cardinal Health Inc. (ISIN US14149Y1082, NYSE: CAH) recently traded around USD 232.65 as of September 16, 2026, with the shares positioned between a 52-week low and a recent peak of USD 258.30, and supported by a market capitalization near USD 54.60 billion at that date, according to Ad-hoc-news.

The same overview cites a recent high of USD 258.30 for Cardinal Health and notes that the stock was trading in the upper half of its 52-week range as of September 16, 2026, underlining that the latest decline still leaves the shares well above their lows over the past year, as summarized from Ad-hoc-news.

Today’s focus for Cardinal Health stock

Cardinal Health has recently highlighted a cash dividend of USD 0.516 per share with an ex-dividend date of October 1, 2026, in its investor information, as reflected on the company’s press release page via Yahoo Finance, so income-focused investors are watching the stock’s path into that date.

The same press release listing on Yahoo Finance shows that Cardinal Health reported its fourth quarter and fiscal year 2026 results and provided fiscal year 2027 guidance about one month ago, which remains a key fundamental backdrop for trading as investors continue to digest the earnings trajectory and guidance into today’s US session.

Disclaimer...

en | US14149Y1082 | CARDINAL HEALTH | boerse | 70121831 | bgmi